[go: up one dir, main page]

AR035923A1 - Empleo de derivados de m-amino-fenil-imino-imidazolidina para la preparacion de medicamentos para el tratamiento de incontinencia de orina ,los derivados de m-amino-fenil-imino-imidazolidina con un nuevo patron de sustituyentes en el anillo de fenilo, un procedimiento para su preparacion y las prepa - Google Patents

Empleo de derivados de m-amino-fenil-imino-imidazolidina para la preparacion de medicamentos para el tratamiento de incontinencia de orina ,los derivados de m-amino-fenil-imino-imidazolidina con un nuevo patron de sustituyentes en el anillo de fenilo, un procedimiento para su preparacion y las prepa

Info

Publication number
AR035923A1
AR035923A1 ARP010104787A ARP010104787A AR035923A1 AR 035923 A1 AR035923 A1 AR 035923A1 AR P010104787 A ARP010104787 A AR P010104787A AR P010104787 A ARP010104787 A AR P010104787A AR 035923 A1 AR035923 A1 AR 035923A1
Authority
AR
Argentina
Prior art keywords
preparation
phenyl
amino
imino
imidazolidine
Prior art date
Application number
ARP010104787A
Other languages
English (en)
Spanish (es)
Inventor
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR035923A1 publication Critical patent/AR035923A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP010104787A 2000-10-14 2001-10-12 Empleo de derivados de m-amino-fenil-imino-imidazolidina para la preparacion de medicamentos para el tratamiento de incontinencia de orina ,los derivados de m-amino-fenil-imino-imidazolidina con un nuevo patron de sustituyentes en el anillo de fenilo, un procedimiento para su preparacion y las prepa AR035923A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14

Publications (1)

Publication Number Publication Date
AR035923A1 true AR035923A1 (es) 2004-07-28

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104787A AR035923A1 (es) 2000-10-14 2001-10-12 Empleo de derivados de m-amino-fenil-imino-imidazolidina para la preparacion de medicamentos para el tratamiento de incontinencia de orina ,los derivados de m-amino-fenil-imino-imidazolidina con un nuevo patron de sustituyentes en el anillo de fenilo, un procedimiento para su preparacion y las prepa

Country Status (23)

Country Link
EP (1) EP1328517A2 (de)
JP (1) JP2004511547A (de)
KR (1) KR20030046503A (de)
CN (1) CN1471514A (de)
AR (1) AR035923A1 (de)
AU (1) AU2002215943A1 (de)
BG (1) BG107711A (de)
BR (1) BR0114603A (de)
CA (1) CA2425563A1 (de)
CZ (1) CZ20031333A3 (de)
DE (1) DE10150312A1 (de)
EA (1) EA200300460A1 (de)
EC (1) ECSP034517A (de)
EE (1) EE200300177A (de)
HU (1) HUP0302245A3 (de)
IL (1) IL155338A0 (de)
MX (1) MXPA03003162A (de)
NO (1) NO20031697L (de)
PL (1) PL361359A1 (de)
SK (1) SK4342003A3 (de)
WO (1) WO2002032876A2 (de)
YU (1) YU28203A (de)
ZA (1) ZA200302345B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
NO20031697D0 (no) 2003-04-11
CN1471514A (zh) 2004-01-28
EE200300177A (et) 2003-08-15
YU28203A (sh) 2006-05-25
NO20031697L (no) 2003-05-26
MXPA03003162A (es) 2004-12-06
ZA200302345B (en) 2004-04-23
WO2002032876A2 (de) 2002-04-25
EP1328517A2 (de) 2003-07-23
CZ20031333A3 (cs) 2003-08-13
BR0114603A (pt) 2003-10-14
KR20030046503A (ko) 2003-06-12
IL155338A0 (en) 2003-11-23
AU2002215943A1 (en) 2002-04-29
PL361359A1 (en) 2004-10-04
HUP0302245A3 (en) 2004-01-28
CA2425563A1 (en) 2002-04-25
WO2002032876A3 (de) 2002-07-18
ECSP034517A (es) 2003-04-25
DE10150312A1 (de) 2002-07-04
HUP0302245A2 (hu) 2003-10-28
JP2004511547A (ja) 2004-04-15
BG107711A (bg) 2004-02-27
EA200300460A1 (ru) 2004-02-26
SK4342003A3 (en) 2003-10-07

Similar Documents

Publication Publication Date Title
PE20212302A1 (es) Inhibidores de apol1 y sus metodos de uso
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
ECSP055746A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
AR037489A1 (es) Quinolinas sustituidas y proceso para su preparacion
UY28034A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparacion asi como su empleo como medicamentos
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
CU23288B7 (es) DERIVADOS DE TROPANO ÃsTILES EN TERAPIA
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
PA8593101A1 (es) Composiciones para el tratamiento de crecimiento celular anormal
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
AR028948A1 (es) Compuestos novedosos
UY28150A1 (es) Agentes terapeuticos
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
AR035110A1 (es) Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto
DE60112960D1 (de) Kondensierte pyridoindolderivate
CO4810376A1 (es) Derivados de eritromicina triciclicos
ES2063117T3 (es) Derivados del tieno(2,3-d)acepina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR035923A1 (es) Empleo de derivados de m-amino-fenil-imino-imidazolidina para la preparacion de medicamentos para el tratamiento de incontinencia de orina ,los derivados de m-amino-fenil-imino-imidazolidina con un nuevo patron de sustituyentes en el anillo de fenilo, un procedimiento para su preparacion y las prepa
DE50304891D1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
UY26147A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
UY27324A1 (es) Nuevas sales de napsilato i
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
CO5550429A2 (es) Formulaciones de lactona y metodos de uso
PA8474401A1 (es) 3-ceto derivados triciclicos de 6-0-metileritromicina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal